5A80.1

ICD-11 MMS 2026-01

Polycystic ovary syndrome

Description

Condition defined by the presence of at least 2 of the following 3 criteria: oligo/anovulation; clinical or biochemical signs of hyperandrogenism; presence of polycystic ovaries as identified by ultrasound.

Index terms

  • Polycystic ovary syndrome
  • PCOS - [polycystic ovary syndrome]
  • Sclerocystic ovary syndrome
Show allHide
  • Stein-Leventhal syndrome

Inclusions

  • Sclerocystic ovary syndrome

Excludes

  • 5A80.2 – Polycystic ovary NOS

Exclusions from above levels

  • 5A61.0 – isolated gonadotropin deficiency
  • 5D44 – Postprocedural ovarian failure
  • 18 – Pregnancy, childbirth or the puerperium
Show allHide
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Sibling codes

  • 5A80.0 – Clinical hyperandrogenism
  • 5A80.2 – Polycystic ovary
  • 5A80.3 – Anovulation
  • 5A80.4 – Oligo-ovulation
  • 5A80.5 – Diminished ovarian reserve
  • 5A80.Y – Other specified ovarian dysfunction
  • 5A80.Z – Ovarian dysfunction, unspecified

Foundation entity

Polycystic ovary syndrome – http://id.who.int/icd/entity/1213633323

Part of: 5A80: Ovarian dysfunction › 05: Endocrine, nutritional or metabolic diseases